Patent intelligence · US
US 7557081
Alpha-1-acid glycoprotein for the treatment of diabetes
Alpha-1-acid glycoprotein for the treatment of diabetes
Patent details — US 7557081
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 7, 2009
- Expiration
- Jul 2, 2029
- Applicant
- Essential Skincare, LLC
- Claims
- 14
- CPC classes
- A61K, A61K38/1709, A61K38/28, A61P
Quick answer
US 7557081 (Alpha-1-acid glycoprotein for the treatment of diabetes) is held by Essential Skincare, LLC. Status: granted. Granted Jul 7, 2009. Expires Jul 2, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Essential Skincare, LLC
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K38/1709, A61K38/28, A61P, A61P3/00, A61P3/10
More from Essential Skincare, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 7557081?
US 7557081 (Alpha-1-acid glycoprotein for the treatment of diabetes) is held by Essential Skincare, LLC. Status: granted. Granted Jul 7, 2009. Expires Jul 2, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7557081?
Essential Skincare, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 7557081 expire?
Our index shows an expiration date of Jul 2, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.